MedPath
TGA Approval

Lysine Growth Tablet (460132)

460132

Lysine Growth Tablet

Australia New Base Pharmaceutical Pty Ltd

August 20, 2024

Medicine

Medicine

Active

Listed

Active Ingredients

choline bitartrate

colecalciferol

Citrus reticulata

fructooligosaccharides

lysine hydrochloride

zinc gluconate

hydroxyapatite

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lysine Growth Tablet (460132) - TGA 批准文号 | MedPath